Existing studies have shown that PRMT6 is upregulated in gliomas and regulates the mitosis and tumorigenicity of glioblastoma stem cells by methylating RCC1, or promotes the proliferation of glioma cells by transcriptionally activating CDC20 [32, 35]. Here, RCC1 is linked to central nervous system cancer.